At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 38 enrolled
Drug / intervention
isoquercetin or quercetindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pharmacokinetic and Pharmacodynamic Study of Oral Quercetin and Isoquercetin in Healthy Adults and Patients With Hypercoagulable States.
In Brief
A Early Phase 1 clinical trial evaluating isoquercetin or quercetin for Healthy. Completed, enrolled 38 participants across 1 site.
Detailed Summary
The goal of this study is to evaluate how much quercetin or isoquercetin is absorbed after a single dose and evaluate for pharmacokinetic inhibition of protein disulfide isomerase. Pharmacodynamic studies will also be performed in an additional cohort of 10 patients with evidence of antiphospholipid antibodies
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
Early Ph 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2012
First PostedNov 2012
Primary CompletionDec 2019
TodayJul 2026
First PostedNov 7, 2012
Enrollment StartMay 1, 2012
Primary CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 7.6 yearsPosted 13.7 years ago
Interventions
isoquercetin or quercetindrug
Single dose PK/PD study